Tyra Biosciences, Inc. (TYRA)
33.02
-0.38
(-1.14%)
USD |
NASDAQ |
May 21, 16:00
33.00
-0.02
(-0.06%)
After-Hours: 19:59
Tyra Biosciences Shareholders Equity (Quarterly) : 387.58M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 670.81M |
| Relay Therapeutics, Inc. | 642.18M |
| Tango Therapeutics, Inc. | 391.51M |
| Entrada Therapeutics, Inc. | 270.85M |
| BioMarin Pharmaceutical, Inc. | 6.212B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 412.04M |
| Total Liabilities (Quarterly) | 24.46M |
| Debt to Equity Ratio | 0.0147 |
| Current Ratio | 20.49 |
| Net Debt Paydown Yield | 0.00% |